These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 8335365

  • 1. Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits.
    Aiura K, Gelfand JA, Burke JF, Thompson RC, Dinarello CA.
    Infect Immun; 1993 Aug; 61(8):3342-50. PubMed ID: 8335365
    [Abstract] [Full Text] [Related]

  • 2. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli.
    Wakabayashi G, Gelfand JA, Jung WK, Connolly RJ, Burke JF, Dinarello CA.
    J Clin Invest; 1991 Jun; 87(6):1925-35. PubMed ID: 2040686
    [Abstract] [Full Text] [Related]

  • 3. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF, Hesse CJ, Jutte NH, Zietse R, Bruining HA, Weimar W.
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [Abstract] [Full Text] [Related]

  • 4. A specific receptor antagonist for interleukin 1 prevents Escherichia coli-induced shock in rabbits.
    Wakabayashi G, Gelfand JA, Burke JF, Thompson RC, Dinarello CA.
    FASEB J; 1991 Mar 01; 5(3):338-43. PubMed ID: 1825816
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia.
    Fischer E, Marano MA, Van Zee KJ, Rock CS, Hawes AS, Thompson WA, DeForge L, Kenney JS, Remick DG, Bloedow DC.
    J Clin Invest; 1992 May 01; 89(5):1551-7. PubMed ID: 1533231
    [Abstract] [Full Text] [Related]

  • 6. Circulating interleukin-1 receptor antagonist concentrations are increased in adult patients with thermal injury.
    Mandrup-Poulsen T, Wogensen LD, Jensen M, Svensson P, Nilsson P, Emdal T, Mølvig J, Dinarello CA, Nerup J.
    Crit Care Med; 1995 Jan 01; 23(1):26-33. PubMed ID: 8001382
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A, Yoshimura T, Miyamoto K, Ohkawara S, Yoshinaga M.
    Lab Invest; 1997 May 01; 76(5):629-38. PubMed ID: 9166282
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin-1 mediates hemodynamic dysfunction and release of eicosanoids and tumor necrosis factor during graded bacteremia.
    Santos MC, Woolley DS, Quinn JV, Slotman GJ.
    Shock; 1999 Jun 01; 11(6):423-8. PubMed ID: 10454832
    [Abstract] [Full Text] [Related]

  • 10. Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production.
    Drenth JP, Van Uum SH, Van Deuren M, Pesman GJ, Van der Ven-Jongekrijg J, Van der Meer JW.
    J Appl Physiol (1985); 1995 Nov 01; 79(5):1497-503. PubMed ID: 8594005
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat.
    Shito M, Wakabayashi G, Ueda M, Shimazu M, Shirasugi N, Endo M, Mukai M, Kitajima M.
    Transplantation; 1997 Jan 15; 63(1):143-8. PubMed ID: 9000676
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Maintenance of dynamic microvascular function and structure in a rat model of endotoxic shock by blockade of the interleukin-1 receptor.
    Norman JG, Sutton ET, Franz MS, Baker CH.
    Shock; 1995 May 15; 3(5):369-75. PubMed ID: 7648339
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of tumor necrosis factor alpha and interleukin-1 receptor antagonist, but not interleukin-1, by human mononuclear cells is enhanced by exposure of whole blood to shear stress.
    Pomianek MJ, Colton CK, Dinarello CA, Miller LC.
    ASAIO J; 1996 May 15; 42(1):52-9. PubMed ID: 8808459
    [Abstract] [Full Text] [Related]

  • 16. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.
    Arthritis Rheum; 2004 Jan 15; 50(1):277-90. PubMed ID: 14730626
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of interleukin-1 receptor antagonist (IL-1RA) and tumor necrosis factor binding protein (TNF-BP) in a rodent abscess model of host resistance.
    Colagiovanni DB, Shopp GM.
    Immunopharmacol Immunotoxicol; 1996 Aug 15; 18(3):397-419. PubMed ID: 8872492
    [Abstract] [Full Text] [Related]

  • 18. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra).
    Swiergiel AH, Smagin GN, Johnson LJ, Dunn AJ.
    Brain Res; 1997 Nov 21; 776(1-2):96-104. PubMed ID: 9439800
    [Abstract] [Full Text] [Related]

  • 19. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ, Ding WH, Gao W, Huo Y, Hong T, Zhu RY, Ma DL.
    Zhonghua Yi Xue Za Zhi; 2004 Apr 02; 84(7):548-53. PubMed ID: 15144587
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV, Saget BM, Wang MZ, Dinarello CA, Skolnik PR.
    Mol Med; 1995 Sep 02; 1(6):667-77. PubMed ID: 8529133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.